Candoxatrilat
Brand names,
Candoxatrilat
Analogs
Candoxatrilat
Brand Names Mixture
Candoxatrilat
Chemical_Formula
C29H41NO7
Candoxatrilat
RX_link
No information avaliable
Candoxatrilat
fda sheet
Candoxatrilat
msds (material safety sheet)
Candoxatrilat
Synthesis Reference
No information avaliable
Candoxatrilat
Molecular Weight
515.638 g/mol
Candoxatrilat
Melting Point
No information avaliable
Candoxatrilat
H2O Solubility
No information avaliable
Candoxatrilat
State
Solid
Candoxatrilat
LogP
4.874
Candoxatrilat
Dosage Forms
No information avaliable
Candoxatrilat
Indication
For treatment of hypertension, improve exercise capacity in patients with CHF receiving angiotensin converting enzyme inhibition.
Candoxatrilat
Pharmacology
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure in man.
Candoxatrilat
Absorption
No information avaliable
Candoxatrilat
side effects and Toxicity
No information avaliable
Candoxatrilat
Patient Information
No information avaliable
Candoxatrilat
Organisms Affected
Humans and other mammals